Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KPTI Karyopharm Therapeutics Inc.

盘后交易 12-24 13:33:12 EST

0.5950

-0.0212

-3.44%

盘后0.6000

+0.0050+0.84%

13:27 EST

最高0.6250	最低0.5910	成交量85.61万
今开0.6015	昨收0.6162	日振幅5.52%
总市值7,456万	流通市值6,830万	总股本1.25亿
成交额51.75万	换手率0.75%	流通股本1.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KPTI","market":"US","secType":"STK","nameCN":"Karyopharm Therapeutics Inc.","latestPrice":0.595,"timestamp":1735063199999,"preClose":0.6162,"halted":0,"volume":856083,"hourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.595,"latestTime":"13:27 EST","volume":7587,"amount":4413.0506265,"timestamp":1735064841165},"delay":0,"floatShares":114793338,"shares":125314506,"eps":-1.080315,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.0212,"latestTime":"12-24 13:33:12 EST","open":0.6015,"high":0.625,"low":0.591,"amount":517479.00789401995,"amplitude":0.055177,"askPrice":0.65,"askSize":20,"bidPrice":0.5753,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.080315,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735077600000},"adr":0,"listingDate":1383714000000,"adjPreClose":0.6162,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.6,"preClose":0.6162,"latestTime":"08:21 EST","volume":7,"amount":4.39010005,"timestamp":1735046497457},"postHourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.595,"latestTime":"13:27 EST","volume":7587,"amount":4413.0506265,"timestamp":1735064841165},"volumeRatio":1.338125,"impliedVol":0.1865,"impliedVolPercentile":0.0754},"requestUrl":"/m/hq/s/KPTI/tweets","defaultTab":"tweets","newsList":[{"id":"2493790515","title":"Karyopharm Therapeutics Inc.盘中异动 快速跳水5.04%报0.603美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493790515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493790515?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:15","pubTimestamp":1734984943,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日04时15分，Karyopharm Therapeutics Inc.股票出现波动，股价快速下挫5.04%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122404154395eadffc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122404154395eadffc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KPTI","LENZ"],"gpt_icon":0},{"id":"2490011440","title":"Karyopharm Therapeutics Inc.盘中异动 股价大跌5.13%报0.732美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490011440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490011440?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:47","pubTimestamp":1733842078,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时47分，Karyopharm Therapeutics Inc.股票出现波动，股价快速下挫5.13%。截至发稿，该股报0.732美元/股，成交量21.757万股，换手率0.17%，振幅4.60%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224758a1e3a057&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224758a1e3a057&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0},{"id":"2485132293","title":"Karyopharm Therapeutics Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485132293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485132293?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:56","pubTimestamp":1732291002,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时56分，Karyopharm Therapeutics Inc.股票出现异动，股价大幅拉升5.16%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122235642a24e469b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122235642a24e469b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KPTI","LENZ"],"gpt_icon":0},{"id":"2484929864","title":"Karyopharm Therapeutics Inc.盘中异动 早盘急速下挫5.17%报0.753美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484929864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484929864?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:30","pubTimestamp":1732030255,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时30分，Karyopharm Therapeutics Inc.股票出现异动，股价大幅跳水5.17%。截至发稿，该股报0.753美元/股，成交量18.1549万股，换手率0.14%，振幅4.47%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.13%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233055971a7776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233055971a7776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0},{"id":"2483929372","title":"Karyopharm Therapeutics Inc.盘中异动 大幅拉升6.13%报0.889美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483929372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483929372?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:35","pubTimestamp":1731681307,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时35分，Karyopharm Therapeutics Inc.股票出现异动，股价快速拉升6.13%。截至发稿，该股报0.889美元/股，成交量1.0587万股，换手率0.01%，振幅1.79%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.46%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522350798e42ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522350798e42ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2483985164","title":"Karyopharm Therapeutics Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483985164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483985164?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:35","pubTimestamp":1731526541,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时35分，Karyopharm Therapeutics Inc.股票出现异动，股价急速下跌5.00%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033541971a65d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033541971a65d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","LENZ"],"gpt_icon":0},{"id":"2482763413","title":"Karyopharm Therapeutics Inc.盘中异动 急速上涨5.02%报0.921美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482763413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482763413?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:58","pubTimestamp":1731358716,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时58分，Karyopharm Therapeutics Inc.股票出现异动，股价快速拉升5.02%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112045836abb70942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112045836abb70942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2482426204","title":"Karyopharm Therapeutics Inc.2024财年第三财季实现净利润-32.07百万美元，同比增加7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482426204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482426204?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:01","pubTimestamp":1731254492,"startTime":"0","endTime":"0","summary":"11月11日，Karyopharm Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-32.07百万美元，同比增加7.07%；其中营业收入为38.78百万美元，同比增加7.69%，每股基本收益为-0.26美元。机构评级：截至2024年11月11日，当前有7家机构对Karyopharm Therapeutics Inc.目标价做出预测，其中目标均价为4.50美元，其中最低目标价为2.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000212abb3631f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000212abb3631f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI"],"gpt_icon":0},{"id":"2481983834","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨5.07%报0.889美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983834?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903577,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Karyopharm Therapeutics Inc.股票出现波动，股价急速上涨5.07%。截至发稿，该股报0.889美元/股，成交量1.5089万股，换手率0.01%，振幅0.00%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223257a21d2af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223257a21d2af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2480398584","title":"Karyopharm Therapeutics Inc.盘中异动 股价大涨5.03%报0.949美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480398584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480398584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730752,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Karyopharm Therapeutics Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报0.949美元/股，成交量6.7489万股，换手率0.05%，振幅2.21%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422323298e40474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422323298e40474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ","BK4139"],"gpt_icon":0},{"id":"2480958882","title":"Karyopharm Therapeutics Inc    预计每股亏损 26 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480958882","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480958882?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:27","pubTimestamp":1730471259,"startTime":"0","endTime":"0","summary":"   * Karyopharm Therapeutics Inc    将于11月5日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于马萨诸塞州牛顿市的公司的营收有望从去年同期的3601万美元增长4.9%，达到3778.9万美元。* LSEG 分析师对 Karyopharm Therapeutics Inc 的平均预期是每股亏损 26 美分。* 华尔街对 Karyopharm Therapeutics Inc 的 12 个月目标价中位数为 4.50 美元，高于其 0.99 美元的最新收盘价。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","KPTI"],"gpt_icon":0},{"id":"2479518682","title":"Karyopharm Therapeutics Inc.盘中异动 临近收盘大幅跳水5.00%报0.855美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479518682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479518682?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:52","pubTimestamp":1730231571,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时52分，Karyopharm Therapeutics Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报0.855美元/股，成交量28.1288万股，换手率0.23%，振幅4.44%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。该公司的收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030035251971a301a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030035251971a301a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2479144283","title":"Karyopharm Therapeutics Inc    预计每股亏损 26 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479144283","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479144283?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:53","pubTimestamp":1730210024,"startTime":"0","endTime":"0","summary":"   * Karyopharm Therapeutics Inc    预计将在10月31日公布截至2024年9月30日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于马萨诸塞州牛顿市的公司的营收有望从去年同期的3601万美元增长5.4%，达到3795.8万美元。* LSEG 分析师对 Karyopharm Therapeutics Inc 的平均预期是每股亏损 26 美分。* 华尔街对 Karyopharm Therapeutics Inc 的 12 个月目标价中位数为 4.50 美元，高于上一交易日 0.90 美元的收盘价。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","LENZ"],"gpt_icon":0},{"id":"2478487948","title":"Karyopharm Therapeutics Inc.盘中异动 快速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478487948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478487948?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:36","pubTimestamp":1730126195,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时36分，Karyopharm Therapeutics Inc.股票出现异动，股价急速拉升5.16%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822363698e3edba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822363698e3edba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KPTI","LENZ"],"gpt_icon":0},{"id":"2472864564","title":"Karyopharm Therapeutics Inc.盘中异动 快速拉升5.09%报0.929美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472864564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472864564?lang=zh_cn&edition=full","pubTime":"2024-10-04 00:14","pubTimestamp":1727972060,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日00时14分，Karyopharm Therapeutics Inc.股票出现波动，股价急速上涨5.09%。截至发稿，该股报0.929美元/股，成交量57.1787万股，换手率0.46%，振幅9.37%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100400142098e3a72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100400142098e3a72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2472719521","title":"Karyopharm Therapeutics Inc.盘中异动 急速上涨5.35%报0.798美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472719521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472719521?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:19","pubTimestamp":1727878774,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时19分，Karyopharm Therapeutics Inc.股票出现波动，股价快速拉升5.35%。截至发稿，该股报0.798美元/股，成交量22.1204万股，换手率0.18%，振幅6.60%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100222193498e3a38c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100222193498e3a38c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2472733192","title":"Karyopharm Therapeutics Inc.盘中异动 下午盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472733192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472733192?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:01","pubTimestamp":1727715675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时01分，Karyopharm Therapeutics Inc.股票出现波动，股价急速上涨5.18%。截至发稿，该股报0.761美元/股，成交量35.1392万股，换手率0.28%，振幅4.70%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001010115ab672ef5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001010115ab672ef5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0},{"id":"2469147087","title":"Karyopharm Therapeutics Inc.盘中异动 急速下挫5.01%报0.701美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469147087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469147087?lang=zh_cn&edition=full","pubTime":"2024-09-24 00:47","pubTimestamp":1727110048,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日00时47分，Karyopharm Therapeutics Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报0.701美元/股，成交量22.738万股，换手率0.18%，振幅6.61%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.92%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004729ab656250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2459207934","title":"Karyopharm Therapeutics Inc.盘中异动 大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459207934","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459207934?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:44","pubTimestamp":1723729477,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时44分，Karyopharm Therapeutics Inc.股票出现波动，股价急速拉升5.17%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521443797198d12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521443797198d12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KPTI","LENZ"],"gpt_icon":0},{"id":"2458492692","title":"Karyopharm Therapeutics Inc.2024财年第二财季实现净利润23.79百万美元，同比增加172.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458492692","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458492692?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392606,"startTime":"0","endTime":"0","summary":"8月12日，Karyopharm Therapeutics Inc.公布财报，公告显示公司2024财年第二财季净利润为23.79百万美元，同比增加172.91%；其中营业收入为42.79百万美元，同比增加13.86%，每股基本收益为0.20美元。机构评级：截至2024年8月12日，当前有7家机构对Karyopharm Therapeutics Inc.目标价做出预测，其中目标均价为4.36美元，其中最低目标价为2.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120010129f2225d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120010129f2225d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.karyopharm.com","stockEarnings":[{"period":"1week","weight":-0.0803},{"period":"1month","weight":-0.2708},{"period":"3month","weight":-0.1238},{"period":"6month","weight":-0.3808},{"period":"1year","weight":-0.2522},{"period":"ytd","weight":-0.2876}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Karyopharm Therapeutics Inc.是一家专注于研发新式一期核运输癌症治疗方法的临床型制药公司。公司的科学专业知识集中于对细胞核和细胞质之间核运输的研究。公司已经研发出全资拥有的，新奇的，小分子式的核运输选择性抑制剂，以及抑制核运输的正弦蛋白质XPO1。公司最重要的候选药物Selinexor (KPT-330)，属于尚在评估中的XPO1抑制剂，该抑制剂尚属于并联标记第一期临在医疗患者中临床试验的阶段，这些试验对象主要包括预防复发或血液和固体的恶性肿瘤。Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州作为一家临床阶段制药公司成立，并在马萨诸塞州的纳迪克拥有了主要营业地点。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.001247},{"month":2,"riseRate":0.636364,"avgChangeRate":0.036877},{"month":3,"riseRate":0.636364,"avgChangeRate":0.109569},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.105953},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.013174},{"month":6,"riseRate":0.545455,"avgChangeRate":0.010739},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.018972},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.022599},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.010356},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.034599},{"month":11,"riseRate":0.727273,"avgChangeRate":0.140432},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.108608}],"exchange":"NASDAQ","name":"Karyopharm Therapeutics Inc.","nameEN":"Karyopharm Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Karyopharm Therapeutics Inc.,KPTI,Karyopharm Therapeutics Inc.股票,Karyopharm Therapeutics Inc.股票老虎,Karyopharm Therapeutics Inc.股票老虎国际,Karyopharm Therapeutics Inc.行情,Karyopharm Therapeutics Inc.股票行情,Karyopharm Therapeutics Inc.股价,Karyopharm Therapeutics Inc.股市,Karyopharm Therapeutics Inc.股票价格,Karyopharm Therapeutics Inc.股票交易,Karyopharm Therapeutics Inc.股票购买,Karyopharm Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}